blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2296706

EP2296706 - PHOTOCHEMICAL INTERNALISATION OF TYROSINE KINASE INHIBITORS [Right-click to bookmark this link]
Former [2011/12]PHOTOCHEMICAL INTERNALISATION OF KINASE INHIBITORS
[2020/03]
StatusNo opposition filed within time limit
Status updated on  29.10.2021
Database last updated on 20.09.2024
FormerThe patent has been granted
Status updated on  20.11.2020
FormerGrant of patent is intended
Status updated on  28.06.2020
FormerExamination is in progress
Status updated on  02.06.2020
FormerGrant of patent is intended
Status updated on  15.01.2020
FormerExamination is in progress
Status updated on  31.08.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
PCI Biotech AS
Ullernchausseen 64
0379 Oslo / NO
[2016/38]
Former [2011/12]For all designated states
PCI Biotech AS
Hoffsveien 48
0377 Oslo / NO
Inventor(s)01 / HØGSET, Anders
Rognerudveien 55A
0681 Oslo / NO
02 / WEYERGANG, Anette
Anne Maries vei 9
0373 Oslo / NO
03 / SELBO, Pål, Kristian
Anne Maries vei 9
0373 Oslo / NO
04 / BERG, Kristian
Heggedalsveien 333
1389 Heggedal / NO
 [2020/51]
Former [2011/12]01 / HØGSET, Anders
Rognerudveien 55A
N-0681 Oslo / NO
02 / WEYERGANG, Anette
Colletts Gate 9A
N-0169 Oslo / NO
03 / SELBO, Pål, Kristian
Colletts Gate 9A
N-0169 Oslo / NO
04 / BERG, Kristian
Vollenveien 158A
n-1389 Heggedal / NO
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2020/52]
Former [2011/12]Jones, Elizabeth Louise
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Application number, filing date09772782.026.06.2009
[2011/12]
WO2009GB01618
Priority number, dateGB2008001195530.06.2008         Original published format: GB 0811955
[2011/12]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010001102
Date:07.01.2010
Language:EN
[2010/01]
Type: A2 Application without search report 
No.:EP2296706
Date:23.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 07.01.2010 takes the place of the publication of the European patent application.
[2011/12]
Type: B1 Patent specification 
No.:EP2296706
Date:23.12.2020
Language:EN
[2020/52]
Search report(s)International search report - published on:EP01.04.2010
ClassificationIPC:A61K41/00, A61K31/277, A61K31/506, A61K31/517, A61P35/00, A61P43/00
[2020/03]
CPC:
A61K41/0071 (EP,US); A61K31/00 (US); A61K31/277 (EP);
A61K31/506 (EP); A61K31/517 (EP); A61K31/5377 (EP);
A61K45/06 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P43/00 (EP); A61P7/00 (EP) (-)
C-Set:
A61K31/277, A61K2300/00 (EP);
A61K31/506, A61K2300/00 (EP);
A61K31/517, A61K2300/00 (EP);
A61K31/5377, A61K2300/00 (EP)
Former IPC [2011/12]A61K41/00, A61P35/00, A61P43/00, A61K31/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2020/52]
Former [2011/12]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:FOTOCHEMISCHE INTERNALISIERUNG VON TYROSINKINASEHEMMERN[2020/03]
English:PHOTOCHEMICAL INTERNALISATION OF TYROSINE KINASE INHIBITORS[2020/03]
French:L'INTERNALISATION PHOTOCHIMIQUE DES INHIBITEURS DE LA TYROSINE KINASE[2020/03]
Former [2011/12]FOTOCHEMISCHE INTERNALISIERUNG VON KINASEHEMMERN
Former [2011/12]PHOTOCHEMICAL INTERNALISATION OF KINASE INHIBITORS
Former [2011/12]PROCÉDÉ
Entry into regional phase23.12.2010National basic fee paid 
23.12.2010Designation fee(s) paid 
23.12.2010Examination fee paid 
Examination procedure23.12.2010Amendment by applicant (claims and/or description)
23.12.2010Examination requested  [2011/12]
19.09.2011Despatch of a communication from the examining division (Time limit: M06)
29.03.2012Reply to a communication from the examining division
30.09.2013Despatch of a communication from the examining division (Time limit: M06)
10.04.2014Reply to a communication from the examining division
18.12.2015Despatch of a communication from the examining division (Time limit: M06)
28.06.2016Reply to a communication from the examining division
17.08.2017Despatch of a communication from the examining division (Time limit: M06)
26.02.2018Reply to a communication from the examining division
10.04.2019Despatch of a communication from the examining division (Time limit: M04)
14.08.2019Reply to a communication from the examining division
16.01.2020Communication of intention to grant the patent
02.06.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
29.06.2020Communication of intention to grant the patent
09.11.2020Fee for grant paid
09.11.2020Fee for publishing/printing paid
09.11.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.09.2011
Opposition(s)24.09.2021No opposition filed within time limit [2021/48]
Fees paidRenewal fee
28.06.2011Renewal fee patent year 03
31.03.2012Renewal fee patent year 04
26.06.2013Renewal fee patent year 05
31.03.2014Renewal fee patent year 06
17.06.2015Renewal fee patent year 07
17.06.2016Renewal fee patent year 08
16.06.2017Renewal fee patent year 09
18.06.2018Renewal fee patent year 10
21.06.2019Renewal fee patent year 11
31.03.2020Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.06.2009
AT23.12.2020
CY23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
MK23.12.2020
MT23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
[2024/41]
Former [2024/22]HU26.06.2009
AT23.12.2020
CY23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
MK23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2023/29]HU26.06.2009
AT23.12.2020
CY23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2023/24]AT23.12.2020
CY23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/34]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
BE30.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/23]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/21]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
IE26.06.2021
LU26.06.2021
CH30.06.2021
LI30.06.2021
Former [2022/18]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
LU26.06.2021
Former [2022/13]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SI23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2022/10]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2022/08]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
MC23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
Former [2021/51]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
ES23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
Former [2021/49]AT23.12.2020
CZ23.12.2020
DK23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
Former [2021/48]AT23.12.2020
CZ23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
IT23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
Former [2021/42]AT23.12.2020
CZ23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
IS23.04.2021
PT23.04.2021
Former [2021/39]AT23.12.2020
CZ23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
PL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/37]AT23.12.2020
CZ23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/36]CZ23.12.2020
EE23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/35]CZ23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
RO23.12.2020
SE23.12.2020
SK23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/34]CZ23.12.2020
FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
SE23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/33]FI23.12.2020
HR23.12.2020
LT23.12.2020
LV23.12.2020
NL23.12.2020
SE23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
PT23.04.2021
Former [2021/30]FI23.12.2020
HR23.12.2020
LV23.12.2020
NL23.12.2020
SE23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
Former [2021/28]FI23.12.2020
HR23.12.2020
LV23.12.2020
SE23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
Former [2021/24]FI23.12.2020
LV23.12.2020
SE23.12.2020
BG23.03.2021
NO23.03.2021
GR24.03.2021
Former [2021/23]FI23.12.2020
LV23.12.2020
SE23.12.2020
NO23.03.2021
GR24.03.2021
Former [2021/22]FI23.12.2020
NO23.03.2021
Former [2021/20]FI23.12.2020
Cited inInternational search[X]WO2008008215  (HEALTH RESEARCH INC [US], et al) [X] 1-3,5-8,10,11,13,15,25-28,30,32,33,35,37-41 * paragraphs [0019] , [0021] , [0033] *;
 [X]  - QINGYU ZHOU ET AL, "Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER, BERLIN, DE, (20051201), vol. 56, no. 6, ISSN 1432-0843, pages 569 - 577, XP019334240 [X] 1-3,5-8,10-12,25-28,30,32,33,35,37-41 * abstract *

DOI:   http://dx.doi.org/10.1007/s00280-005-1017-0
 [X]  - BRIGGS C H ET AL, "The effect of combination treatment with gemcitabine and the EGFR-receptor tyrosine kinase inhibitor Iressa with photodynamic therapy in bladder cancer.", EUROPEAN UROLOGY SUPPLEMENTS, & XVIIITH CONGRESS OF THE EUROPEAN ASSOCIATION OF UROLOGY; MADRID, SPAIN; MARCH 12-15, 2003, (200302), vol. 2, no. 1, ISSN 1569-9056, page 44, XP002554492 [X] 1-3,5-8,10-13,15,25-28,30,32,33,35,37-41 * abstract *

DOI:   http://dx.doi.org/10.1016/S1569-9056(03)80175-6
 [PX]  - WEYERGANG A ET AL, "Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478", PHOTOCHEMICAL AND PHOTOBIOLOGICAL SCIENCES 2008 GB, (2008), vol. 7, no. 9, ISSN 1474-905X 1474-9092, pages 1032 - 1040, XP008114552 [PX] 1-3,5-12,14,15,19,20,25-28,30,32,33,35,37-41 * abstract *

DOI:   http://dx.doi.org/10.1039/b806209a
 [PX]  - WEYERGANG ANETTE ET AL, "Photodynamic therapy targets the mTOR signaling network in vitro and in vivo.", MOLECULAR PHARMACEUTICS 2009 JAN-FEB, (200901), vol. 6, no. 1, ISSN 1543-8384, pages 255 - 264, XP002554493 [PX] 1,2,4,7-9,11-13,17,20,25-28,30,32,33,35,37-41 * abstract *

DOI:   http://dx.doi.org/10.1021/MP800156E
 [A]  - SELBO P K ET AL, "PHOTOCHEMICAL INTERNALISATION: A NOVEL DRUG DELIVERY SYSTEM", TUMOR BIOLOGY, KARGER, BASEL, CH, (20020301), vol. 23, no. 2, ISSN 1010-4283, pages 103 - 112, XP009059847

DOI:   http://dx.doi.org/10.1159/000059713
ExaminationWO0054802
 WO0244396
 WO0244395
by applicantWO2008008215
    - ZHOU ET AL., CANCER CHEMOTHERAPY AND PHARMACOLOGY, (2005), vol. 56, pages 569 - 577
    - BRIGGS ET AL., EUROPEAN UROLOGY SUPPLEMENTS, (2003), vol. 2, page 44
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.